Advertisement

Biological Products

Open Access
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin and Eugene P. Rhee

CJASN December 2019, CJN.07420619; DOI: https://doi.org/10.2215/CJN.07420619

Add to Selected Citations
You have accessRestricted Access
Clinical Trial End Points for Hemodialysis Vascular Access
Surendra Shenoy, Michael Allon, Gerald Beathard, Deborah Brouwer-Maier, Laura M. Dember, Mark Glickman, Celeste Lee, Terry Litchfield, Charmaine Lok, Thomas Huber, Prabir Roy-Chaudhury, Jack Work, Melissa West and Haimanot Wasse

CJASN March 2018, 13 (3) 490-494; DOI: https://doi.org/10.2215/CJN.13321216

Add to Selected Citations
You have accessRestricted Access
Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology
Laura H. Mariani, William F. Pendergraft and Matthias Kretzler

CJASN November 2016, 11 (11) 2054-2060; DOI: https://doi.org/10.2215/CJN.13651215

Add to Selected Citations